Perbedaan Indofarma Tbk. dan Nusantara Sawit Sejahtera Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Nusantara Sawit Sejahtera Tbk. diperdagangkan di Rp800 (kapitalisasi pasar 19,64 T, volume 24 jam 5,37 jt). Perbedaan utamanya: Nusantara Sawit Sejahtera Tbk. jauh lebih besar — sekitar 50,3× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | NSSS | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 19,64 T |
Volume | — | 5,37 jt |
Lot | — | 53,75 rb |
Perputaran | — | 4,24 M |
Harga Rata-rata | — | 788,88 |
Nilai Transaksi | — | 4,24 M |
Harga Ekuilibrium Indikatif | — | 800 |
Volume Ekuilibrium Indikatif | — | 537 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Selengkapnya di halaman NSSS →